(1)
Cooper, D.; Moisan, J.; Abdous, B.; Grégoire, J.-P. A POPULATION-BASED COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE AND RISPERIDONE AMONG AMBULATORY PATIENTS WITH SCHIZOPHRENIA. J Popl Ther Clin Pharmacol 2018, 15.